Skip to content

The Effect of Combined Volitional and Reactive Step Training in Reducing Falls Risk in Older Fallers

The Immediate and Sustained Effect of 4-week Combined Volitional and Reactive Step Training in Reducing Falls Risk in Community-Dwelling Older Fallers: a Randomised Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06378164
Enrollment
98
Registered
2024-04-22
Start date
2023-12-01
Completion date
2026-04-30
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older Adults With a History of Falls

Keywords

Falls, Exercise, Randomised Trial, Step Training, Reaction

Brief summary

To examine the immediate and sustained effect of a 4-week combined volitional and reactive step training on fall risks in community-dwelling older fallers.

Interventions

BEHAVIORALExercise

For the combined step training group, the participants will receive training on both volitional and reactive stepping. The training will last for 1 hours per session, 2 session per week for 4 weeks.

BEHAVIORALActive Control

An active control group will be used to minimise the placebo and history effect. The group will also receive a 4-week programme with the frequency and duration of the training and the instructor-to-participant ratio that match the combined step training group. During training, they will perform exercises not specific to reducing fall risk.

Sponsors

Chinese University of Hong Kong
CollaboratorOTHER
Neuroscience Research Australia
CollaboratorOTHER
The University of New South Wales
CollaboratorOTHER
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Community-dwelling * Able to walk for 1 minute under supervision without walking aids * Have a history of falling in the past year

Exclusion criteria

* Cognitive impairment (i.e., scores below the age and education-specific cut-off of 7th percentile in the 5-minute Montreal cognitive assessment) * Blindness * Neurological conditions (e.g., stroke, Parkinson's disease) * Other serious illnesses that preclude participation in exercise training

Design outcomes

Primary

MeasureTime frameDescription
Choice Stepping Reaction Times(i) baseline, (ii) immediately post-intervention, (iii) 3-months post-intervention and (iv) 6-months post-interventionTo assess volitional stepping performance
Spring Scale Test(i) baseline, (ii) immediately post-intervention, (iii) 3-months post-intervention and (iv) 6-months post-interventionTo assess reactive stepping performance

Secondary

MeasureTime frameDescription
Falls Efficacy Scale - International(i) baseline, (ii) immediately post-intervention, (iii) 3-months post-intervention and (iv) 6-months post-intervention
Trail-Making Test(i) baseline, (ii) immediately post-intervention, (iii) 3-months post-intervention and (iv) 6-months post-intervention
Mini Balance Evaluation System Test(i) baseline, (ii) immediately post-intervention, (iii) 3-months post-intervention and (iv) 6-months post-intervention
Prospective FallsFrom start to 12 months after the intervention endsFall incidence and details on fall will be recorded using a fall diary and monthly follow-up.
Adverse EventsFrom start to six months after the end of trainingAdverse events happened during the intervention will be recorded descriptively.
Programme AdherenceFrom start to six months after the end of trainingThe attendance of the exercise class will be recorded.
Motor Control Test(i) baseline, (ii) immediately post-intervention, (iii) 3-months post-intervention and (iv) 6-months post-intervention

Countries

Hong Kong

Contacts

Primary ContactFreddy Man Hin LAM, PhD
freddy-mh.lam@polyu.edu.hk2766 6720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026